Item Posts Archive - Page 22 of 1770 - Medivizor
Navigation Menu

Comparing the long-term outcomes of percutaneous coronary intervention with everolimus-eluting stents versus coronary artery bypass grafting in patients with mutltivessel coronary artery disease.

Comparing the long-term outcomes of percutaneous coronary intervention with everolimus-eluting stents versus coronary artery bypass grafting in patients with mutltivessel coronary artery disease.

Posted by on Mar 26, 2023 in Coronary artery disease | 0 comments

In a nutshell This study compared the long-term outcomes of percutaneous coronary intervention (PCI) using everolimus (Afinitor)-eluting stents (Xience) versus coronary artery bypass grafting (CABG) in patients with multivessel coronary artery disease (CAD). The data showed that both treatments were associated with a similar risk of heart attack, stroke,...

Read More

Comparing the effects of acupuncture combined with metformin versus metformin alone on pregnancy rate in women with polycystic ovary syndrome.

Comparing the effects of acupuncture combined with metformin versus metformin alone on pregnancy rate in women with polycystic ovary syndrome.

Posted by on Mar 26, 2023 in Infertility | 0 comments

In a nutshell This study evaluated the effects of acupuncture combined with metformin (Glucophage) versus metformin alone on pregnancy rate in women with polycystic ovary syndrome (PCOS). The data showed that acupuncture combined with metformin improved the pregnancy rate, ovulation rate, and insulin resistance compared with metformin treatment alone in...

Read More

Which sequence of treatment should be given first- immunotherapy or targeted therapy for patients with BRAF-mutated metastatic melanoma?

Which sequence of treatment should be given first- immunotherapy or targeted therapy for patients with BRAF-mutated metastatic melanoma?

Posted by on Mar 26, 2023 in Melanoma | 0 comments

In a nutshell This study evaluated which sequence of treatment should be given first – immunotherapy or targeted therapy – for the most clinical benefit in patients with BRAF-mutated metastatic melanoma. The data showed that immunotherapy followed by targeted therapy significantly improved survival outcomes in these patients. Some background...

Read More

Evaluating the effectiveness and safety outcomes of atezolizumab given before surgery in patients with non-small cell lung cancer.

Evaluating the effectiveness and safety outcomes of atezolizumab given before surgery in patients with non-small cell lung cancer.

Posted by on Mar 26, 2023 in Lung cancer | 0 comments

In a nutshell This study evaluated the effectiveness and safety outcomes of atezolizumab (Tecentriq) given before surgery for the treatment of patients with non-small cell lung cancer (NSCLC). The data showed that atezolizumab given before surgery was safe and effective for patients with NSCLC. Some background Non-small cell lung cancer (NSCLC)...

Read More

Evaluating the effectiveness and safety of high-dose rosuvastatin combined with telmisartan or amlodipine on glucose metabolism in hypertensive patients with impaired fasting glucose.

Evaluating the effectiveness and safety of high-dose rosuvastatin combined with telmisartan or amlodipine on glucose metabolism in hypertensive patients with impaired fasting glucose.

Posted by on Mar 26, 2023 in Hypertension | 0 comments

In a nutshell This study evaluated the effectiveness and safety of high-dose rosuvastatin (Crestor) combined with telmisartan (Micardis) or amlodipine (Norvasc) on glucose metabolism in patients with atherosclerotic cardiovascular disease (ASCVD), hypertension (high blood pressure), and impaired fasting glucose (IFG or prediabetes). The...

Read More